1. Scrip
  2. >>Therapy Areas

Valeant On Upswing With Walgreens Deal

 
• By Lisa LaMotta

In its latest effort to turn around its image and recoup its sales after its distribution network went bust, Valeant Pharmaceuticals is teaming up with Walgreens to offer its dermatology and ophthalmology products at discounted rates.

Valeant announced Dec. 15 that it has inked a 20-year deal with the nation's largest retail pharmacy chain to distribute...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Dermatological

More from Therapy Areas

Scholar Rock Shows Muscle-Building PoC In Obesity

 
• By Jessica Merrill

The company said it intends to maintain a focus on rare neuromuscular disease with apitegromab but could consider partnering in obesity.

Spyre Takes Aim At Roche And J&J In Inflammatory Diseases

 
• By Andrew McConaghie

The US firm was already looking to compete in ulcerative colitis, but now expands its ambitions by moving into rheumatoid arthritis as well.

Draig Is All Fired Up To Transform Neuropsychiatric Field

 
• By Kevin Grogan

Wales-based group launches with $140m series A.